HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sydney Ch'ng Selected Research

Facial Nerve Diseases (Facial Nerve Disorders)

1/2022Bilateral facial neuritis associated with dabrafenib and trametinib after failure of neoadjuvant immunotherapy for stage III melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sydney Ch'ng Research Topics

Disease

18Melanoma (Melanoma, Malignant)
08/2022 - 01/2006
10Neoplasms (Cancer)
08/2022 - 01/2006
8Neoplasm Metastasis (Metastasis)
04/2022 - 01/2006
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 12/2006
3Lymphatic Metastasis
01/2022 - 01/2021
3Squamous Cell Carcinoma of Head and Neck
01/2020 - 07/2013
2Wounds and Injuries (Trauma)
12/2013 - 02/2012
1Rhabdomyosarcoma
04/2022
1Facial Nerve Diseases (Facial Nerve Disorders)
01/2022
1Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2022
1Brain Neoplasms (Brain Tumor)
01/2022
1Colitis
01/2019
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2016
1Facial Asymmetry
12/2013
1Malocclusion (Crossbite)
12/2013
1Infections
02/2012
1Basal Cell Carcinoma (Rodent Ulcer)
01/2006

Drug/Important Bio-Agent (IBA)

4IpilimumabIBA
01/2022 - 01/2019
4NivolumabIBA
01/2022 - 01/2019
3DNA (Deoxyribonucleic Acid)IBA
08/2022 - 01/2018
2Biological ProductsIBA
01/2022 - 12/2006
2dabrafenibIBA
01/2022 - 01/2019
2trametinibIBA
01/2022 - 01/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2022
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2020
1Circulating Tumor DNAIBA
11/2019
1CytosineIBA
01/2019
1ThymineIBA
01/2019
1EnzymesIBA
01/2019
1ParaffinIBA
01/2018
1Formaldehyde (Formol)FDA Link
01/2018
1Immune Checkpoint InhibitorsIBA
08/2017
1Pyridinolcarbamate (P23)IBA
02/2013
1P 11 (P-11)IBA
02/2013
1GoldIBA
02/2012
1IntegrinsIBA
01/2009
1Cadherins (E-Cadherin)IBA
01/2009
1CateninsIBA
01/2009
1Biomarkers (Surrogate Marker)IBA
03/2008
1ErbB Receptors (EGF Receptor)IBA
03/2008
1Proteins (Proteins, Gene)FDA Link
03/2008
1Peptide Hydrolases (Proteases)FDA Link
01/2006
1Interleukin-8 (Interleukin 8)IBA
01/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2006
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2006
1Proteoglycans (Proteoglycan)IBA
01/2006
1Heparin (Liquaemin)FDA LinkGeneric
01/2006

Therapy/Procedure

13Therapeutics
08/2022 - 07/2013
4Immunotherapy
08/2022 - 01/2021
4Lymph Node Excision (Lymph Node Dissection)
01/2022 - 12/2019
3Adjuvant Radiotherapy
08/2022 - 07/2013
3Free Tissue Flaps
04/2022 - 01/2014
2Neoadjuvant Therapy
01/2021 - 01/2019
2Neck Dissection (Radical Neck Dissection)
12/2019 - 02/2013
1Radiotherapy
01/2022
1Metastasectomy
10/2021
1Bone-Anchored Prosthesis
01/2016
1Osteotomy
12/2013
1Dental Models
12/2013